420 related articles for article (PubMed ID: 11865380)
1. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
3. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis.
Lashner BA; Bauer WM; Rybicki LA; Goldblum JR
Am J Gastroenterol; 2003 Jun; 98(6):1423-7. PubMed ID: 12818291
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis.
Lashner BA; Shapiro BD; Husain A; Goldblum JR
Am J Gastroenterol; 1999 Feb; 94(2):456-62. PubMed ID: 10022646
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
7. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for carcinoma of the pelvic ileal pouch/anal canal in ulcerative colitis.
Elkowitz D; Daum F; Markowitz J; Proccaccino J; Boas E; Cuomo J; Kahn E
Ann Clin Lab Sci; 2004; 34(2):143-9. PubMed ID: 15228225
[TBL] [Abstract][Full Text] [Related]
9. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts.
Yoshida T; Mikami T; Mitomi H; Okayasu I
J Pathol; 2003 Feb; 199(2):166-75. PubMed ID: 12533829
[TBL] [Abstract][Full Text] [Related]
10. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
[TBL] [Abstract][Full Text] [Related]
11. Cancer biology in ulcerative colitis and potential use in endoscopic surveillance.
Shapiro BD; Lashner BA
Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):453-68. PubMed ID: 9177146
[TBL] [Abstract][Full Text] [Related]
12. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
13. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.
Arai N; Mitomi H; Ohtani Y; Igarashi M; Kakita A; Okayasu I
Mod Pathol; 1999 Jun; 12(6):604-11. PubMed ID: 10392637
[TBL] [Abstract][Full Text] [Related]
14. Risk of colorectal cancer in ulcerative colitis in India.
Venkataraman S; Mohan V; Ramakrishna BS; Peter S; Chacko A; Chandy G; Kurian G; Kurian S; Mathan M; Mathan VI; Patra S; Pulimood A; Rolston DD
J Gastroenterol Hepatol; 2005 May; 20(5):705-9. PubMed ID: 15853982
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.
Chaubert P; Benhattar J; Saraga E; Costa J
Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776
[TBL] [Abstract][Full Text] [Related]
16. Increased claudin-1 protein expression contributes to tumorigenesis in ulcerative colitis-associated colorectal cancer.
Kinugasa T; Akagi Y; Yoshida T; Ryu Y; Shiratuchi I; Ishibashi N; Shirouzu K
Anticancer Res; 2010 Aug; 30(8):3181-6. PubMed ID: 20871038
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of p53 protein in neoplastic changes in ulcerative colitis: immunohistochemical study.
Ajioka Y; Watanabe H; Matsuda K
J Gastroenterol; 1995 Nov; 30 Suppl 8():33-5. PubMed ID: 8563884
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
Maruyama K; Saigusa N; Baba S; Kino I
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
[TBL] [Abstract][Full Text] [Related]
19. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
Rosman-Urbach M; Niv Y; Birk Y; Smirnoff P; Zusman I; Morgenstern S; Schwartz B
Dis Colon Rectum; 2004 Mar; 47(3):304-13. PubMed ID: 14991492
[TBL] [Abstract][Full Text] [Related]
20. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
Sundblad AS; Chumbita RL; Zoppi JA
Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
